能谱CT预测肝硬化食管胃静脉曲张首次出血风险
回顾性研究纳入195例肝硬化食管胃静脉曲张(EGV)患者,基于门静脉期能谱CT定量、静脉形态学与临床指标构建预测首次出血的列线图。联合模型AUC为0.912(95%CI: 0.864-0.960),bootstrap校正后为0.880(95%CI: 0.787-0.951),优于各单项指标。
要点
- 联合模型预测首次出血AUC达0.912,bootstrap校正后为0.880。
- 六项预测因子为EGV NIC、Liver Eff-Z、SMVD、PVD、淋巴细胞计数与ALT。
- 门静脉期能谱CT可同时评估EGV碘浓度、肝Z值与门静脉系统径线。
核心结论
- 综合能谱CT血流动力学、门静脉形态学与临床指标的多参数列线图对肝硬化EGV患者首次出血风险具有高精度无创预测价值。
研究设计与样本
- 回顾性研究,纳入195例肝硬化EGV患者,均行门静脉期能谱CT;经单因素与多因素logistic回归筛选独立预测因素并构建列线图。
- 内部验证采用bootstrap重抽样200次。
关键影像表现/征象
- 食管胃静脉曲张归一化碘浓度(EGV NIC)为独立预测因子之一。
- 肝脏有效原子序数(Liver Eff-Z)为独立预测因子之一。
- 肠系膜上静脉直径(SMVD)与门静脉直径(PVD)为静脉形态学独立预测因子。
诊断标准与关键数值
- 联合模型预测首次出血的AUC为0.912(95%CI: 0.864-0.960)。
- 联合模型AUC高于所有单项预测因子(AUC范围0.636-0.835;DeLong检验均P<0.05)。
- Bootstrap内部验证校正后AUC为0.880(95%CI: 0.787-0.951)。
- 校准图显示预测概率与观察到的出血结局一致性良好,决策曲线分析提示联合模型在相关阈值概率范围内净获益更高。
临床应用与阅片要点
- 门静脉期能谱CT可同时提供EGV NIC、Liver Eff-Z、SMVD与PVD,便于出血风险分层。
- 报告肝硬化EGV患者时可关注上述能谱CT定量与血管径线,并结合淋巴细胞计数与ALT。
- 联合列线图可用于无创预测首次出血,辅助临床干预决策。
局限性
- 研究为回顾性设计,存在选择偏倚可能。
- 仅采用bootstrap内部验证,缺乏外部验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: To develop a multiparametric model integrating spectral CT quantitative metrics, venous morphometrics, and clinical biomarkers for the noninvasive prediction of initial bleeding risk in cirrhotic patients with esophagogastric varices (EGV).
MATERIALS AND METHODS: This retrospective study evaluated a cohort of 195 cirrhotic patients with EGV who underwent portal venous spectral CT. Univariable and multivariable logistic regression analyses were conducted to screen spectral CT metrics, venous morphometrics, and clinical biomarkers, aiming to identify independent predictive factors for initial bleeding. A joint diagnostic model was subsequently constructed based on these independent predictors and formulated as a nomogram. Model discrimination was quantified via the area under the receiver operating characteristic curve (AUC) and compared using the DeLong test, calibration was visually assessed using calibration plots, and clinical utility was evaluated using decision curve analysis (DCA). Internal validation was performed using bootstrap resampling (200 repetitions).
RESULTS: Following feature selection, six predictors of initial bleeding were identified: EGV normalized iodine concentration (EGV NIC), liver effective atomic number (Liver Eff-Z), superior mesenteric vein diameter (SMVD), portal vein diameter (PVD), lymphocyte count, and alanine aminotransferase (ALT). The integrated multiparametric model demonstrated high apparent discriminative performance, with an AUC of 0.912 (95% CI, 0.864-0.960), significantly exceeding the AUCs of all individual predictors (AUC range, 0.636-0.835; all P < 0.05 by pairwise DeLong tests). Calibration analysis showed good agreement between predicted probabilities and observed bleeding outcomes. Bootstrap internal validation yielded an optimism-corrected AUC of 0.880 (95% CI, 0.787-0.951). Decision curve analysis suggested that the joint model provided greater net benefit across a range of clinically relevant threshold probabilities.
CONCLUSION: A multiparametric nomogram synergizing selected spectral CT hemodynamics, portal morphometrics, and clinical profiles provides a highly accurate and noninvasive tool for predicting initial bleeding risk in cirrhotic patients with EGV.
引用
- Gao, Wang, Yu, et al. Spectral CT predicts initial bleeding risk in cirrhotic patients with esophagogastric varices. Abdom Radiol (NY). 2026. PMID: 42773279. doi:10.1007/s00261-026-05803-8
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。